Eden Research plc (LON:EDEN – Get Free Report) shot up 2.8% during trading on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares were traded during trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Stock Up 2.8 %
The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.25. The firm’s fifty day moving average price is GBX 3.88 and its 200-day moving average price is GBX 4.01. The company has a market cap of £19.73 million, a price-to-earnings ratio of -200.00 and a beta of 0.92.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Articles
- Five stocks we like better than Eden Research
- How to Most Effectively Use the MarketBeat Earnings Screener
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Quiet Period Expirations Explained
- What Does the Future Hold for Eli Lilly?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.